Case guide

7-OH Lawsuit: Claims Over 7-Hydroxymitragynine Tablets, Shots and Gummies

7-OH is a strong opioid chemical made from kratom. It is sold as tablets, gummies and shots.

See If You Qualify

No obligation · About 2 minutes

Updated Nov 14, 202630 sources

This may apply to you if

  • A loved one died after using kratom or a 7-OH product.
  • For a death, the autopsy or toxicology report shows an overdose of kratom (mitragynine) or 7-OH. You can start before you have it.
  • You or a loved one had an overdose or other serious harm after using kratom or 7-OH, and it left lasting damage.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

U.S. Drug Enforcement Administration · Federal agency that schedules controlled drugs

Finding: DEA’s toxicology program found 7-OH in 85 overdose cases since 2019, and 55 were fatal. Samples often also held other drugs, such as fentanyl. DEA said neither it nor HHS has found these substances safe below its proposed limit.

DEA notice of intent to place 7-OH and mitragynine pseudoindoxyl above a threshold in Schedule I, 91 FR 65370 (Oct. 14, 2026) (opens in a new tab) · Oct 14, 2026 · Checked Nov 12, 2026

The evidence and its limits

FDA Center for Drug Evaluation and Research · 2025

7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat

Design:
Agency review
Finding:
FDA concludes that 7-OH acts on the same brain receptors as opioids and produces respiratory depression, physical dependence and withdrawal symptoms like those of morphine, fentanyl and oxycodone.
Main limitation
Much of the data comes from animal studies, poison center calls and drug-test surveillance, not controlled human trials. FDA notes that other drugs and unlabeled products make single cases hard to interpret.

Read the source: 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat (opens in a new tab) · Checked Nov 12, 2026

U.S. Food and Drug Administration · 2025

Letter to health care professionals about 7-OH

Design:
Agency review
Finding:
FDA told doctors that, aside from addiction, 7-OH side effects include withdrawal symptoms, insomnia and anxiety, seizures and fatal respiratory depression.
Main limitation
A safety letter that summarizes FDA’s assessment; it does not report a new study.

Read the source: Letter to health care professionals about 7-OH (opens in a new tab) · Checked Nov 12, 2026

U.S. Drug Enforcement Administration · 2026

Notice of intent to temporarily place 7-OH and mitragynine pseudoindoxyl above a threshold in Schedule I

Design:
Agency review
Finding:
DEA reports that its toxicology program found 7-OH in 85 overdose cases since 2019, 55 of them fatal. Poison centers logged 165 7-OH exposures from January through July 2025; among people exposed to 7-OH alone, 35 percent had serious health problems. Reported effects include seizures, a racing heart and trouble breathing.
Main limitation
Many overdose samples also held other drugs, such as fentanyl, benzodiazepines or ketamine. Surveillance counts show what was found, not that 7-OH alone caused each harm.

Read the source: Notice of intent to temporarily place 7-OH and mitragynine pseudoindoxyl above a threshold in Schedule I (opens in a new tab) · Checked Nov 12, 2026

The short answer

What is a 7-OH lawsuit?
It is a claim against a company that made or sold a 7-OH product. Families and users say these products led to overdoses, addiction and deaths. The FDA calls 7-OH an opioid that can be stronger than morphine. [1]
What has the government found about 7-OH?
The DEA says 7-OH carries risks of dependence, addiction, slowed breathing and death. Its drug testing program found 7-OH in 85 overdose cases since 2019, and 55 people died. Many samples also held other drugs, such as fentanyl. [6]
Which 7-OH companies got FDA warning letters?
In July 2025, the FDA announced warning letters to seven companies selling 7-OH. They include 7Tabz Retail, Thang Botanicals, which sold 7OHMZ, and Hydroxie. A warning letter is the FDA’s view, not a court ruling. [20]
Is there a 7-OH class action lawsuit?
Yes, buyers have filed some. A class action against 7Tabz was filed on January 23, 2026, the National Law Review reported. These cases are about how the products were sold; injury and death claims are filed one by one. [29]

What rules a case out

Not covered by this case

  • This page is not medical advice. If you use kratom or 7-OH and want to stop, a doctor can help.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

7-OH is a strong opioid chemical made from kratom. It is sold as tablets, gummies and shots. Families are suing the companies that made and sold it.

What is a 7-OH lawsuit?

It is a claim against a company that made or sold a 7-OH product. Families and users say these products led to overdoses, addiction and deaths. The FDA calls 7-OH an opioid that can be stronger than morphine.

7-OH is short for 7-hydroxymitragynine. It occurs in tiny amounts in kratom leaves. Sellers now concentrate it and sell it as tablets, gummies, drink mixes and shots, the FDA says.

The FDA is most worried about products that appeal to young people. It points to fruit-flavored gummies and ice cream cones. It also says some products are not clearly labeled and are sometimes sold as kratom.

What has the government found about 7-OH?

The DEA says 7-OH carries risks of dependence, addiction, slowed breathing and death. Its drug testing program found 7-OH in 85 overdose cases since 2019, and 55 people died. Many samples also held other drugs, such as fentanyl.

The FDA reached a similar view in a 2025 report. FDA scientists say 7-OH produces slowed breathing, physical dependence and withdrawal like opioid painkillers do. In a letter to doctors, the FDA listed seizures and “fatal respiratory depression” among its side effects.

Poison centers logged 165 cases of 7-OH exposure from January through July 2025, the DEA said. Among people exposed to 7-OH alone, 35% had serious health problems. Two in three were treated at a health care facility.

Which 7-OH companies got FDA warning letters?

In July 2025, the FDA announced warning letters to seven companies selling 7-OH. They include 7Tabz Retail, Thang Botanicals, which sold 7OHMZ, and Hydroxie. A warning letter is the FDA’s view, not a court ruling.

The other four were Shaman Botanicals, My Smoke Wholesale, RRR Trading (also called EDP Kratom) and Royal Diamond Imports, which sold Roxytabs. The FDA said they were illegally marketing products with 7-OH.

In December 2025, the FDA said U.S. Marshals seized about 73,000 units of 7-OH products from three Missouri firms. Missouri later sued CBD American Shaman. The company agreed in June 2026 to stop selling kratom and 7-OH in the state, without admitting liability.

Is there a 7-OH class action lawsuit?

Yes, buyers have filed some. A class action against 7Tabz was filed on January 23, 2026, the National Law Review reported. These cases are about how the products were sold; injury and death claims are filed one by one.

States have joined the 7-OH litigation too. Texas says lab tests found a seller’s products had 86% to 96% 7-OH, far above the state’s 2% cap. Its suit against Smokey’s Paradise was filed in February 2026. These are the state’s claims.

There is no MDL or class action for 7-OH injuries or deaths. If 7-OH hurt you or a loved one, your claim would be your own. Read who qualifies.

Is 7-OH being banned?

The DEA proposed putting concentrated 7-OH in Schedule I on October 14, 2026. It said the order would be published on or after November 13, 2026. Several states already ban it.

The proposal covers products with more than 1 milligram of 7-OH per gram. It also covers products that have less than 100 times as much mitragynine, kratom’s main chemical, as 7-OH. Our guide on whether 7-OH is illegal tracks the federal and state rules.

Hurt by a 7-OH product, or lost someone? Tell us what happened using the questions on this page.

People’s Justice is not a law firm and does not give legal advice. We connect people with law firms, who may pay us for those connections. How we make money.

Find out where you stand.

The review is private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. FDA news release on restricting 7-OH opioid products (July 29, 2025)FDA news release on restricting 7-OH opioid products (July 29, 2025) · regulator
  2. mctlaw (the Coyne and Talavera families’ law firm), kratom lawsuits page (read Nov. 12, 2026)mctlaw (the Coyne and Talavera families’ law firm), kratom lawsuits page (read Nov. 12, 2026)
  3. NBC News, report on the Talavera award (July 31, 2023)NBC News, report on the Talavera award (July 31, 2023)
  4. FDA, FDA and Kratom (page current as of Dec. 2, 2025; read Nov. 12, 2026)FDA, FDA and Kratom (page current as of Dec. 2, 2025; read Nov. 12, 2026) · regulator
  5. FDA letter to health care professionals about 7-OH (July 29, 2025)FDA letter to health care professionals about 7-OH (July 29, 2025) · regulator
  6. DEA notice of intent to place 7-OH and mitragynine pseudoindoxyl above a threshold in Schedule I, 91 FR 65370 (Oct. 14, 2026)DEA notice of intent to place 7-OH and mitragynine pseudoindoxyl above a threshold in Schedule I, 91 FR 65370 (Oct. 14, 2026) · regulator
  7. DEA temporary scheduling order for mitragynine pseudoindoxyl, MGM-15 and MGM-16 (Aug. 26, 2026)DEA temporary scheduling order for mitragynine pseudoindoxyl, MGM-15 and MGM-16 (Aug. 26, 2026) · court
  8. Texas Attorney General news release on its suit against Smokey’s Paradise (Feb. 9, 2026)Texas Attorney General news release on its suit against Smokey’s Paradise (Feb. 9, 2026) · regulator
  9. In re Botanic Tonics Litigation, No. 3:23-cv-01460-VC (N.D. Cal.), order granting final approval (Oct. 20, 2025)In re Botanic Tonics Litigation, No. 3:23-cv-01460-VC (N.D. Cal.), order granting final approval (Oct. 20, 2025) · court
  10. State of Arizona v. Botanic Tonics, LLC, Superior Court of Arizona, Maricopa County, complaint (filed September 2026)State of Arizona v. Botanic Tonics, LLC, Superior Court of Arizona, Maricopa County, complaint (filed September 2026) · court
  11. NPR, Herbal supplement kratom targeted by lawsuits after a string of deaths (July 24, 2023)NPR, Herbal supplement kratom targeted by lawsuits after a string of deaths (July 24, 2023) · regulator
  12. Coyne v. Chin 2 Corp., No. 57409-8-II, Washington Court of Appeals, Division II (unpublished opinion, Aug. 29, 2023)Coyne v. Chin 2 Corp., No. 57409-8-II, Washington Court of Appeals, Division II (unpublished opinion, Aug. 29, 2023) · court
  13. Filippelli v. Grow, LLC, No. 9:22-cv-81731 (S.D. Fla.), ECF No. 73, final default judgment (signed July 26, 2023; docket-stamped copy posted by the family’s law firm)Filippelli v. Grow, LLC, No. 9:22-cv-81731 (S.D. Fla.), ECF No. 73, final default judgment (signed July 26, 2023; docket-stamped copy posted by the family’s law firm) · court
  14. In re Botanic Tonics Litigation, No. 3:23-cv-01460-VC (N.D. Cal.), settlement agreement and release (signed March 2025)In re Botanic Tonics Litigation, No. 3:23-cv-01460-VC (N.D. Cal.), settlement agreement and release (signed March 2025) · court
  15. City of Baltimore news release on its O.P.M.S. kratom lawsuit (July 30, 2026)City of Baltimore news release on its O.P.M.S. kratom lawsuit (July 30, 2026) · regulator
  16. Missouri Attorney General news release on its suit against CBD American Shaman (March 31, 2026)Missouri Attorney General news release on its suit against CBD American Shaman (March 31, 2026) · regulator
  17. Missouri Attorney General news release on the American Shaman settlement (June 4, 2026)Missouri Attorney General news release on the American Shaman settlement (June 4, 2026) · regulator
  18. Kentucky Revised Statutes 413.140, one-year limit for injury claims (checked Oct. 5, 2026)Kentucky Revised Statutes 413.140, one-year limit for injury claims (checked Oct. 5, 2026) · regulator
  19. Texas Civil Practice and Remedies Code 16.003, two-year limit for injury and death claims (checked Oct. 5, 2026)Texas Civil Practice and Remedies Code 16.003, two-year limit for injury and death claims (checked Oct. 5, 2026) · statute
  20. FDA news release on warning letters to seven 7-OH sellers (July 15, 2025)FDA news release on warning letters to seven 7-OH sellers (July 15, 2025) · regulator
  21. Florida Attorney General news release on the expanded 7-OH emergency rule (June 22, 2026)Florida Attorney General news release on the expanded 7-OH emergency rule (June 22, 2026)
  22. Congressional Research Service, Legal Sidebar LSB11457 on kratom and 7-OH scheduling (updated Oct. 6, 2026)Congressional Research Service, Legal Sidebar LSB11457 on kratom and 7-OH scheduling (updated Oct. 6, 2026)
  23. FDA consumer guide, What You Need to Know About 7-OH (July 2025)FDA consumer guide, What You Need to Know About 7-OH (July 2025) · regulator
  24. Wightman and Hu, A Case of 7-Hydroxymitragynine Use Requiring Inpatient Medically Managed Withdrawal, Journal of Addiction Medicine (2025)Wightman and Hu, A Case of 7-Hydroxymitragynine Use Requiring Inpatient Medically Managed Withdrawal, Journal of Addiction Medicine (2025) · study
  25. U.S. Judicial Panel on Multidistrict Litigation, pending MDL dockets (report dated Nov. 2, 2026)U.S. Judicial Panel on Multidistrict Litigation, pending MDL dockets (report dated Nov. 2, 2026) · court
  26. FDA, 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat (July 2025)FDA, 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat (July 2025) · regulator
  27. CDC, MMWR: Unintentional Drug Overdose Deaths with Kratom Detected, 27 States (April 12, 2019)CDC, MMWR: Unintentional Drug Overdose Deaths with Kratom Detected, 27 States (April 12, 2019) · regulator
  28. Eldridge, Foster and Wyble, Neonatal Abstinence Syndrome Due to Maternal Kratom Use, Pediatrics (December 2018)Eldridge, Foster and Wyble, Neonatal Abstinence Syndrome Due to Maternal Kratom Use, Pediatrics (December 2018) · study
  29. National Law Review, report on the 7Tabz class action (January 2026)
  30. FDA news release on the seizure of 7-OH products in Missouri (Dec. 2, 2025)FDA news release on the seizure of 7-OH products in Missouri (Dec. 2, 2025) · regulator

Checked against 20 primary sources by People's Justice editors

Fact-checked

How we make money

People's Justice research team · Updated Nov 14, 2026